Fosun Group and Shanghai Pharma place interest in Arbor Pharmaceuticals

By Catherine Sturman
Fosun Group and Shanghai Pharmaceuticals have recently stated their interest in bidding for a stake in US company Arbor Pharmaceuticals. One of the lar...

Fosun Group and Shanghai Pharmaceuticals have recently stated their interest in bidding for a stake in US company Arbor Pharmaceuticals.

One of the largest pharmaceutical group’s in China, Fosun Group focuses on the production of new medicines which are exported worldwide, whilst utilising exceptional technologies within its research and development facilities. In a stock exchange filing, it has been revealed that the company’s potential stake in Arbor has been financially backed by private equity firm KKR & Co LP, according to Reuters.

On the same day, Shanghai Pharma also placed its bid. Dually listed on the stock exchange in Shanghai and Hong Kong, the company has retained its position as a leader within manufacturing and distribution of chemical and bio-pharmaceutical products within China, and has partnered with a number of universities across the country.

Related stories

Both companies are looking at acquiring a 20-30% stake in Arbor, according to those who are familiar with the deal. The company has also bought Bank of American Merrill Lynch on board to help ensure any potential sale goes smoothly.

Arbor Pharmaceuticals markets prescription products for “cardiovascular, hospital, neuroscience and paediatric markets,” supplying prescription drugs such as edarbi, cetylev, horizant and evekeo.

Share

Featured Articles

Snowflake: Transforming patient healthcare with Gen AI

Jesse Cugliotta, Healthcare & Life Science at Snowflake, discusses revolutionising healthcare efficiency and improving patient care with Gen AI

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

Digital Healthcare

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML